{"id":"W4367668438","doi":"10.1093/eurheartj/ehad197","title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":331,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi; Western University","funders":"Esperion Therapeutics; Silence Therapeutics; GlaxoSmithKline; HLS Therapeutics; Swedish Orphan Biovitrum; Servier; Daiichi-Sankyo; Amryt Pharma; Astellas Pharma; Regeneron Pharmaceuticals; Mylan; Ionis Pharmaceuticals; AstraZeneca; Amarin Corporation; REGENXBIO; Danone; Alexion Pharmaceuticals; Kowa Company; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Ironwood Pharmaceuticals, Incorporated; Medpace; Ultragenyx Pharmaceutical","keywords":"Medicine; Familial hypercholesterolemia; Genetic testing; Statement (logic); Lipoprotein(a); Intensive care medicine; Family medicine; Physical therapy; Pediatrics; Internal medicine; Lipoprotein; Cholesterol","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005036689,0.001096287,0.001952407,0.003024962,0.0007070377,0.002714744,0.002300889,0.008227495,0.02374784],"category_scores_gemma":[0.02119302,0.0006415432,0.002268302,0.001989697,0.0006121755,0.001997367,0.00141969,0.006265225,0.02235782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002681709,"about_ca_system_score_gemma":0.006779614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01321604,"about_ca_topic_score_gemma":0.01816157,"domain_scores_codex":[0.9965456,0.0009556965,0.0006887353,0.0001819233,0.001365638,0.000262302],"domain_scores_gemma":[0.9874247,0.0033914,0.00124228,0.0001777247,0.006823057,0.0009407978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003225381,0.00002120629,0.00008941764,0.0006205217,0.00001649171,0.00008316602,0.00002369644,0.00006568855,0.00004926314,0.000629926,0.9373286,0.06103988],"study_design_scores_gemma":[0.00004890376,0.00001938868,0.0004497458,0.003185379,0.000036912,0.0002257811,0.00002255834,0.00004408957,0.00002964543,0.0008056822,0.9951179,0.00001406274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.0008514209,0.3431633,0.004471816,0.4415398,0.1081866,0.0006935234,0.01115101,0.0007745447,0.08916801],"genre_scores_gemma":[0.006585734,0.4299266,0.01760269,0.3357096,0.0762298,0.002191528,0.02791961,0.0005962148,0.1032383],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02374784,"threshold_uncertainty_score":0.07944441,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.101228137989068,"score_gpt":0.3599020968927974,"score_spread":0.2586739589037294,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}